DURECT

1 follower

DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.

Industries

Employees

51-200

Links


Org chart

President & CEO
Collapse
SVP, Operations & Corporate Quality Assurance
EVP, Research & Development & Principal Scientist
Executive Director Information Technology
CFO

Board & advisors

Director
Director
Director
Director
Chair of the Board